Pure Global
NCT06384911

InvesT1D: Promoting Adolescent Investment in Diabetes Care

Seattle Children's Hospital·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes
Drug/Device/Intervention
Financial Incentives Program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Seattle Children's Hospital
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Feb 01, 2028
Enrollment
96 participants
Primary outcome

Time In Range

Summary

The goal of this clinical trial is to see if a financial incentives program called InvesT1D
 is helpful to support diabetes management in adolescents with type 1 diabetes.
 
 Adolescent participants will be randomized to usual care or receive financial incentives for
 meeting diabetes self-management and clinical outcomes goals during the study. Researchers
 will compare changes in glucose levels and person-reported outcomes between groups.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384911
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06384911 through Pure Global AI's free database. This phase not specified trial is sponsored by Seattle Children's Hospital and is currently Not yet recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.